"Development, Preclinical, and Clinical Testing of Candidate AIDS Vaccines."

According to an abstract submitted by the authors to the 11th International Conference on AIDS, held July 7-12, 1996, in Vancouver, British Columbia, "Objective: To encourage and support the development of a safe and effective AIDS vaccine(s) through basic and applied research, including testing in animals and humans, is a major goal of the NIAID Vaccine and Prevention Research Program (VPRP). Methods: The correlate(s) of immune protection against HIV-1 are unknown. It is anticipated that both vaccine-induced humoral and cellular immune responses may be required for protection. As HIV is transmitted sexually across mucous membranes, a vaccine may also need to induce...

Want to see the full article?

• Purchase this article for only $3.00